Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease. Mov Disord 2014;29:75-82. | USF Parkinson's Disease and Movement Disorders Center

LeWitt, PA, FJ Huff, RA Hauser, D Chen, D Lissin, K Zomorodi, and KC Cundy. 2014. “Double-Blind Study of the Actively Transported Levodopa Prodrug XP21279 in Parkinson’s Disease. Mov Disord 2014;29:75-82.”. Mov Disord.

Last updated on 10/03/2024